Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells

scientific article published on 18 December 2003

Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1210/ME.2003-0053
P698PubMed publication ID14684844
P5875ResearchGate publication ID8951305

P50authorTaixing CuiQ41770087
P2093author name stringZhen Li
Lan Wu
Jian-Mei Li
Masaru Iwai
Masatsugu Horiuchi
Tetsuya Shiuchi
Li-Juan Min
Clara Nahmias
Midori Okumura
P2860cites workAngiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphataseQ43744720
P433issue3
P304page(s)666-678
P577publication date2003-12-18
P1433published inMolecular EndocrinologyQ3319475
P1476titleRegulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells
P478volume18

Reverse relations

cites work (P2860)
Q37531017AT(2) receptor and tissue injury: therapeutic implications
Q38208962AT2 receptors targeting cardiac protection post-myocardial infarction
Q45016505Accumulation of inhibitory kappaB-alpha as a mechanism contributing to the anti-inflammatory effects of surfactant protein-A.
Q36114299Activation of angiotensin II type 2 receptor suppresses TNF-α-induced ICAM-1 via NF-кB: possible role of ACE2
Q40238417Angiotensin II Type 2-Receptor Agonist C21 Reduces Proteinuria and Oxidative Stress in Kidney of High-Salt-Fed Obese Zucker Rats
Q55022988Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury.
Q38004057Angiotensin II type 2 receptor agonists--where should they be applied?
Q37986143Angiotensin II type 2 receptor agonists: where should they be applied?
Q36042466Angiotensin II type 2 receptor-stimulated activation of plasma prekallikrein and bradykinin release: role of SHP-1.
Q33830299Angiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells
Q46813413Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models
Q33627982Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration
Q36546985Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo
Q37091141Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures
Q54636220Differential expression of angiotensin receptors in human cutaneous wound healing.
Q48643095Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice
Q38029918Impact of the AT(2) receptor agonist C21 on blood pressure and beyond
Q37348839Interferon-beta treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1.
Q39724003LOX-1 transcription
Q37301528Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype
Q28591529Microtubule associated tumor suppressor 1 deficient mice develop spontaneous heart hypertrophy and SLE-like lymphoproliferative disease
Q37033330Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating disease
Q36516285Nuclear factor-kappaB as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injury
Q28571720Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker rats
Q35995120The CD4(+) AT2R(+) T cell subpopulation improves post-infarction remodelling and restores cardiac function
Q36836455The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury
Q37622572The past, present and future of angiotensin II type 2 receptor stimulation
Q40309305The proinflammatory actions of angiotensin II are dependent on p65 phosphorylation by the IkappaB kinase complex
Q37081057c-kit(+)AT2R(+) Bone Marrow Mononuclear Cell Subset Is a Superior Subset for Cardiac Protection after Myocardial Infarction.

Search more.